首页> 外文学位 >Towards new therapies for endovascular revascularization procedures.
【24h】

Towards new therapies for endovascular revascularization procedures.

机译:寻求用于血管内血运重建程序的新疗法。

获取原文
获取原文并翻译 | 示例

摘要

Surgical revascularization by either natural or synthetic grafts, as well as less invasive percutaneous transluminal angioplasty (PTA), with or without stent implantation, is currently used in the treatment of vascular diseases. Despite its less invasive nature, stent implantation remains limited by in-stent restenosis within the stent struts. Although systemic administration of therapeutic drugs has shown disappointing results, the local delivery or presentation of therapeutic molecules/drugs/genetic material is a promising area for development.; The work that forms the basis of this thesis attempts to develop new devices or new strategies to achieve more efficient delivery of therapeutic biomacromolecules to the vascular walls during revascularization procedures. The work can be divided into three 3 Parts: (I) Modification of endovascular stents by hybrid coatings: two strategies involved the surface modification of the devices by plasma polymerization, followed by covalent immobilization of hyaluronan conjugated or able to be conjugated with a bioactive component (peptides/proteins or radionuclides). The last section of the Part I described the development of bioactive coating based on the Layer-by-Layer self-assembly of polysaccharide multilayers. (II) Development of a biodegradable membrane-covered stent: A chitosan-PEG blend has been used to engineer a biodegradable membrane-covered device for endovascular procedures. This membrane-covered device was able to sustain physiologic pressure, showed very small water permeability, displayed an appropriate haemocompatibility and could be used for drug delivery. (III) Development of nanocoatings to be self-assembled in situ onto the vascular wall: self-assembled multilayers have been investigated to protect damaged arteries and to control the healing processes by efficiently delivering therapeutic biomolecules to the vascular wall. These nanometric coatings have been deposited onto blood vessel by the Layer-by-Layer technique and have shown great potential for drug delivery of various macromolecules such as NO-donor or plasmid DNA.
机译:通过天然或合成移植物的外科血管重建术以及侵入性较小的经皮经皮腔内血管成形术(PTA),伴有或不伴有支架植入,目前被用于治疗血管疾病。尽管其侵入性较小,但是支架植入仍然受到支架支柱内支架内再狭窄的限制。尽管全身给药治疗药物显示令人失望的结果,但是治疗分子/药物/遗传物质的局部递送或呈递是有希望的发展领域。构成本论文基础的工作试图开发新的设备或新策略,以在血运重建过程中将治疗性生物大分子更有效地递送至血管壁。这项工作可以分为三个三个部分:(I)通过混合涂层修饰血管内支架:两种策略涉及通过等离子聚合对装置进行表面修饰,然后共价固定或可与生物活性成分结合的透明质酸的共价固定。 (肽/蛋白质或放射性核素)。第一部分的最后一部分描述了基于多糖多层的逐层自组装的生物活性涂层的开发。 (II)可生物降解的覆膜支架的开发:壳聚糖-PEG共混物已被用于设计用于血管内手术的可生物降解的膜覆膜装置。这种被膜覆盖的装置能够维持生理压力,显示出非常小的水渗透性,显示出适当的血液相容性,并且可以用于药物递送。 (III)开发可在血管壁上原位自组装的纳米涂层:已经研究了自组装的多层以保护受损的动脉并通过有效地将治疗性生物分子递送至血管壁来控制愈合过程。这些纳米涂层已通过逐层技术沉积在血管上,并显示出了巨大的潜力,可用于各种大分子(如NO供体或质粒DNA)的药物输送。

著录项

  • 作者

    Thierry, Benjamin.;

  • 作者单位

    McGill University (Canada).;

  • 授予单位 McGill University (Canada).;
  • 学科 Engineering Biomedical.; Health Sciences Medicine and Surgery.
  • 学位 Ph.D.
  • 年度 2004
  • 页码 300 p.
  • 总页数 300
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物医学工程;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号